In vitro metabolism of clenbuterol and bromobuterol by pig liver microsomes

Xenobiotica

Volumn 28, Issue 11, 1998, Pages 1049-1060

  Montesissa, C ^a   Anfossi, P ^b   Biancotto, G ^c   Angeletti, R ^c  

^a Ist di Patol ed Igiene Veterinaria   (Italy)

^b Dipto San Pubblica Vet Patol A   (Italy)

^c ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BROMOBUTEROL; CLENBUTEROL; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; DRUG METABOLISM; GAS CHROMATOGRAPHY; HEAT TREATMENT; LIVER MICROSOME METABOLISM; MASS SPECTROMETRY; NONHUMAN; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0031798726     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598238949     Document Type: Article

References (24)

1. ANFOSSI, P., ZAGHINI, A. and MONTESISSA, C. 1996, Effect of Aflatoxin B1 administration on salbutamol and clenbuterol metabolism in growing lambs. Proceedings of the IX International IUPAC Symposium on Mycotoxins and Phytotoxins, 1, 224.
2. BLAKE, B. L., ROSE, L. R., MAILMAN, R. B., LEVI, P. E. and HODGSON, E. 1995, Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-containing monooxygenases. Xenobiotica, 25, 377-393.
3. BICKEL, M. H. 1969, The pharmacology and biochemistry of N-oxides. Pharmacological Review, 21, 325-355.
4. DIRECTIVE 96/22/EC, 1996, Prohibition of the use of certain substances having an hormonal and thyreostatic action and β-agonists in animal husbandry. Official Journal of European Community, L125.
5. DEBRAUWER, L. and BORIES, G. 1993, Determination of clenbuterol residues by liquid chromatography-electrospray mass spectrometry. Analitica Chimica Acta, 275, 231-239.
6. DEBRAUWER, L., ZALKO, D. and TULLIEZ, J. 1996, LC-ESI-MS for the characterization of Clenbuterol metabolites in the urine. Proceedings Euroresidues III Conference, 1, 367-369.
7. DOERGE, D. R., BAJIC, S. and LOWES, S. 1993, Analysis of clenbuterol in human plasma using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometry. Rapid Communications in Mass Spectrometry, 7, 462-464.
8. ELLIOTT, C. T., KROOKS, S. R. H. and MCCAUGHEY, W. J. 1995, Development of a rapid screening test to detect β-agonist residues in bovine eye and hair. Veterinary Record, 137, 643-644.
9. KAIBAF, M., SEPAI, O. and LAMB, J. H. 1992, Identification of metabolites of 4,4′-diaminodiphenylmethane (methylene dianiline) using liquid chromatographic and mass spectrometric techniques. Journal of Chromatography Biomedical Application, 583, 63-76.
10. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J. 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
11. MALUCELLI, A., RIZZO, A. and MEYER, H. H. D. 1995, Purification of clenbuterol, salbutamol, and terbutaline by immunoaffinity chromatography. Archiv fur Lebensmittelhygiene, 46, 101-103.
12. MERSMANN, H. J. 1989, Influence of infused β-adrenergic agonists on porcine blood metabolites and catecholamines. Journal of Animal Science, 67, 2633-2645.
13. OMURA, T. and SATO, R. 1964, The carbon mono-oxide binding pigment of liver microsomes. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370-2378.
14. POU, K., ONG, H., ADAM, A., LAMOTHE, P. and DELAHAUT, P. 1994, Combined immunoextraction approach coupled to a chemiluminescence enzyme immunoassay for the determination of trace levels of salbutamol and clenbuterol in tissue samples. Analyst, 119, 2659-2662.
15. POULSEN, L. L. and ZIEGLER, D. M. 1995, Multisubstrate flavin-containing monooxygenases: applications of mechanism to specificity. Chemical-Biological Interactions, 96, 57-63.
16. SABOURIN, P. J. and HODGSON, E. 1984, Characterization of the purified microsomal FAD-containing monooxygenase from mouse and pig liver. Chemical-Biological Interactions, 51, 125-139.
17. SAUER, M. J., PICKETT, R. J. H., LIMER, S. and DIXON, S. N. 1995, Distribution and elimination of clenbuterol in tissues and fluids of calves following prolonged oral administration at a growth-promoting dose. Journal of Veterinary Pharmacology and Therapeutics, 18, 81-86.
18. SAUER, M. J., GRAHAM, P. J., LAKE, B. G., HOWELLS, L. and COLDHAM, N. G. 1996, β-agonist abuse in food producing animals: studies of in vitro liver metabolism to evaluate potential target residues. Proceedings of the Euroresidues III Conference, 2, 844-847.
19. SMITH D. J. 1998 The pharmacokinetics, metabolism and tissue residues of β-adrenergic agonists in livestock. Journal of Animal Science, 76, 173-194
20. VISSER, T., VREDENBREGT, M. J., JONG, A. P. J. M. DE, ROSSUM, H. J. VAN, STEPHANY, R. W. and GINKEL, L. A. VAN 1994, Confirmational analysis of beta-agonists by criotrapping gas chromatography Fourier transform infrared spectrometry. Analyst, 119, 2681-2685.
21. WILSON, R. T., GRONECK, J. M., HOLLAND, K. P. and HENRY, A. C. 1994, Determination of Clenbuterol in cattle, sheep and swine tissues by electron ionization gas-chromatography/mass spectrometry. Journal of AOAC-international, 77, 917-924.
22. 3H-clenbuterol in the rat and bovine. Proceedings of the Euroresidues III Conference, 2, 993-997.
23. ZIEGLER, D. M. 1988, Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metabolism Reviews, 19, 1-32.
24. ZIEGLER, D. M. 1993, Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annual Review of Pharmacology and Toxicology, 33, 179-199.